Cellebrite DI Ltd. (NASDAQ: CLBT) Stock Competitors & Peer Comparison
See CLBT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CLBT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLBT | $11.23 | -0.84% | 2.8B | 48.32 | $0.23 | N/A |
| MSFT | $495.63 | +0.65% | 3.7T | 28.68 | $17.28 | +0.73% |
| ORCL | $150.28 | -1.74% | 432.5B | 19.68 | $7.63 | +1.32% |
| PLTR | $167.23 | +0.83% | 384B | 139.36 | $1.20 | N/A |
| PANW | $330.65 | -2.32% | 269.3B | 87.89 | $3.76 | N/A |
| CRWD | $206.74 | -1.02% | 210.5B | 201.21 | $1.03 | N/A |
| FTNT | $156.07 | -1.75% | 114.5B | 51.85 | $3.01 | N/A |
| NET | $306.53 | -1.49% | 108.8B | 303.50 | $1.01 | N/A |
| SNPS | $397.38 | +0.05% | 76.1B | 29.63 | $13.41 | N/A |
| VMW | $142.48 | -4.96% | 61.5B | 42.92 | $3.32 | N/A |
Stock Comparison
Microsoft Corporation (NASDAQ: MSFT)
CLBT vs MSFT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, MSFT has a market cap of 3.7T. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while MSFT trades at $495.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas MSFT's P/E ratio is 28.68. In terms of profitability, CLBT's ROE is +0.12%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, CLBT is more volatile compared to MSFT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check MSFT's competition here
Oracle Corporation (NYSE: ORCL)
CLBT vs ORCL Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ORCL has a market cap of 432.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ORCL trades at $150.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ORCL's P/E ratio is 19.68. In terms of profitability, CLBT's ROE is +0.12%, compared to ORCL's ROE of +0.42%. Regarding short-term risk, CLBT is less volatile compared to ORCL. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check ORCL's competition here
Palantir Technologies Inc. (NASDAQ: PLTR)
CLBT vs PLTR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PLTR has a market cap of 384B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PLTR trades at $167.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PLTR's P/E ratio is 139.36. In terms of profitability, CLBT's ROE is +0.12%, compared to PLTR's ROE of +0.37%. Regarding short-term risk, CLBT is more volatile compared to PLTR. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PLTR's competition here
Palo Alto Networks, Inc. (NASDAQ: PANW)
CLBT vs PANW Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PANW has a market cap of 269.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PANW trades at $330.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PANW's P/E ratio is 87.89. In terms of profitability, CLBT's ROE is +0.12%, compared to PANW's ROE of +0.02%. Regarding short-term risk, CLBT is less volatile compared to PANW. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check PANW's competition here
CrowdStrike Holdings, Inc. (NASDAQ: CRWD)
CLBT vs CRWD Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CRWD has a market cap of 210.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CRWD trades at $206.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CRWD's P/E ratio is 201.21. In terms of profitability, CLBT's ROE is +0.12%, compared to CRWD's ROE of +0.01%. Regarding short-term risk, CLBT is less volatile compared to CRWD. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check CRWD's competition here
Fortinet, Inc. (NASDAQ: FTNT)
CLBT vs FTNT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, FTNT has a market cap of 114.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while FTNT trades at $156.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas FTNT's P/E ratio is 51.85. In terms of profitability, CLBT's ROE is +0.12%, compared to FTNT's ROE of +1.88%. Regarding short-term risk, CLBT is more volatile compared to FTNT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check FTNT's competition here
Cloudflare, Inc. (NYSE: NET)
CLBT vs NET Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NET has a market cap of 108.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NET trades at $306.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NET's P/E ratio is 303.50. In terms of profitability, CLBT's ROE is +0.12%, compared to NET's ROE of -0.14%. Regarding short-term risk, CLBT is less volatile compared to NET. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NET's competition here
Synopsys, Inc. (NASDAQ: SNPS)
CLBT vs SNPS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SNPS has a market cap of 76.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SNPS trades at $397.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SNPS's P/E ratio is 29.63. In terms of profitability, CLBT's ROE is +0.12%, compared to SNPS's ROE of +0.04%. Regarding short-term risk, CLBT is more volatile compared to SNPS. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SNPS's competition here
VMware, Inc. (NYSE: VMW)
CLBT vs VMW Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while VMW trades at $142.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas VMW's P/E ratio is 42.92. In terms of profitability, CLBT's ROE is +0.12%, compared to VMW's ROE of +3.99%. Regarding short-term risk, CLBT is more volatile compared to VMW. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check VMW's competition here
Nebius Group N.V. (NASDAQ: NBIS)
CLBT vs NBIS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NBIS has a market cap of 53.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NBIS trades at $224.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NBIS's P/E ratio is -112.84. In terms of profitability, CLBT's ROE is +0.12%, compared to NBIS's ROE of +0.01%. Regarding short-term risk, CLBT is less volatile compared to NBIS. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NBIS's competition here
Block, Inc. (NYSE: SQ)
CLBT vs SQ Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SQ trades at $83.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SQ's P/E ratio is 49.98. In terms of profitability, CLBT's ROE is +0.12%, compared to SQ's ROE of -0.04%. Regarding short-term risk, CLBT is more volatile compared to SQ. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SQ's competition here
CoreWeave, Inc. Class A Common Stock (NASDAQ: CRWV)
CLBT vs CRWV Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CRWV has a market cap of 48.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CRWV trades at $88.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CRWV's P/E ratio is -44.10. In terms of profitability, CLBT's ROE is +0.12%, compared to CRWV's ROE of -0.45%. Regarding short-term risk, CLBT is more volatile compared to CRWV. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CRWV's competition here
Block, Inc. (NYSE: XYZ)
CLBT vs XYZ Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, XYZ has a market cap of 47.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while XYZ trades at $79.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas XYZ's P/E ratio is 25.88. In terms of profitability, CLBT's ROE is +0.12%, compared to XYZ's ROE of +0.02%. Regarding short-term risk, CLBT is more volatile compared to XYZ. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check XYZ's competition here
Twilio Inc. (NYSE: TWLO)
CLBT vs TWLO Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, TWLO has a market cap of 34.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while TWLO trades at $227.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas TWLO's P/E ratio is 43.13. In terms of profitability, CLBT's ROE is +0.12%, compared to TWLO's ROE of +0.14%. Regarding short-term risk, CLBT is more volatile compared to TWLO. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check TWLO's competition here
MongoDB, Inc. (NASDAQ: MDB)
CLBT vs MDB Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, MDB has a market cap of 29.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while MDB trades at $362.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas MDB's P/E ratio is 68.47. In terms of profitability, CLBT's ROE is +0.12%, compared to MDB's ROE of +0.02%. Regarding short-term risk, CLBT is more volatile compared to MDB. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check MDB's competition here
Gen Digital Inc. Contingent Value Rights (NASDAQ: GENVR)
CLBT vs GENVR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GENVR has a market cap of 28.2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GENVR trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GENVR's P/E ratio is 1.65. In terms of profitability, CLBT's ROE is +0.12%, compared to GENVR's ROE of +0.42%. Regarding short-term risk, CLBT is less volatile compared to GENVR. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check GENVR's competition here
Net Element, Inc. (NASDAQ: NETE)
CLBT vs NETE Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NETE trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NETE's P/E ratio is N/A. In terms of profitability, CLBT's ROE is +0.12%, compared to NETE's ROE of +1.98%. Regarding short-term risk, CLBT is less volatile compared to NETE. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NETE's competition here
Okta, Inc. (NASDAQ: OKTA)
CLBT vs OKTA Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, OKTA has a market cap of 27.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while OKTA trades at $166.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas OKTA's P/E ratio is 47.03. In terms of profitability, CLBT's ROE is +0.12%, compared to OKTA's ROE of +0.04%. Regarding short-term risk, CLBT is less volatile compared to OKTA. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check OKTA's competition here
Corpay, Inc. (NYSE: CPAY)
CLBT vs CPAY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CPAY has a market cap of 26.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CPAY trades at $408.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CPAY's P/E ratio is 16.63. In terms of profitability, CLBT's ROE is +0.12%, compared to CPAY's ROE of +0.30%. Regarding short-term risk, CLBT is more volatile compared to CPAY. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CPAY's competition here
Zscaler, Inc. (NASDAQ: ZS)
CLBT vs ZS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ZS has a market cap of 26.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ZS trades at $164.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ZS's P/E ratio is 41.76. In terms of profitability, CLBT's ROE is +0.12%, compared to ZS's ROE of -0.03%. Regarding short-term risk, CLBT is more volatile compared to ZS. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ZS's competition here
VeriSign, Inc. (NASDAQ: VRSN)
CLBT vs VRSN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, VRSN has a market cap of 26.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while VRSN trades at $292.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas VRSN's P/E ratio is 32.34. In terms of profitability, CLBT's ROE is +0.12%, compared to VRSN's ROE of -0.39%. Regarding short-term risk, CLBT is more volatile compared to VRSN. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check VRSN's competition here
Splunk Inc. (NASDAQ: SPLK)
CLBT vs SPLK Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SPLK trades at $156.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SPLK's P/E ratio is 103.22. In terms of profitability, CLBT's ROE is +0.12%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, CLBT is more volatile compared to SPLK. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SPLK's competition here
F5, Inc. (NASDAQ: FFIV)
CLBT vs FFIV Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, FFIV has a market cap of 23.2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while FFIV trades at $411.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas FFIV's P/E ratio is 24.36. In terms of profitability, CLBT's ROE is +0.12%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, CLBT is more volatile compared to FFIV. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check FFIV's competition here
Samsara Inc. (NYSE: IOT)
CLBT vs IOT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, IOT has a market cap of 22.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while IOT trades at $38.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas IOT's P/E ratio is 61.90. In terms of profitability, CLBT's ROE is +0.12%, compared to IOT's ROE of +0.06%. Regarding short-term risk, CLBT is less volatile compared to IOT. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check IOT's competition here
FLEETCOR Technologies, Inc. (NYSE: FLT)
CLBT vs FLT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while FLT trades at $303.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas FLT's P/E ratio is 22.97. In terms of profitability, CLBT's ROE is +0.12%, compared to FLT's ROE of +0.30%. Regarding short-term risk, CLBT is more volatile compared to FLT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check FLT's competition here
CyberArk Software Ltd. (NASDAQ: CYBR)
CLBT vs CYBR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CYBR trades at $408.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CYBR's P/E ratio is -139.06. In terms of profitability, CLBT's ROE is +0.12%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, CLBT is more volatile compared to CYBR. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CYBR's competition here
Joint Stock Company Kaspi.kz (NASDAQ: KSPI)
CLBT vs KSPI Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, KSPI has a market cap of 19B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while KSPI trades at $99.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas KSPI's P/E ratio is 9.21. In terms of profitability, CLBT's ROE is +0.12%, compared to KSPI's ROE of +0.41%. Regarding short-term risk, CLBT is more volatile compared to KSPI. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check KSPI's competition here
Toast, Inc. (NYSE: TOST)
CLBT vs TOST Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, TOST has a market cap of 18.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while TOST trades at $32.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas TOST's P/E ratio is 28.93. In terms of profitability, CLBT's ROE is +0.12%, compared to TOST's ROE of +0.24%. Regarding short-term risk, CLBT is more volatile compared to TOST. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check TOST's competition here
Gen Digital Inc. (NASDAQ: GEN)
CLBT vs GEN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GEN has a market cap of 18.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GEN trades at $30.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GEN's P/E ratio is 11.46. In terms of profitability, CLBT's ROE is +0.12%, compared to GEN's ROE of +0.42%. Regarding short-term risk, CLBT is more volatile compared to GEN. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GEN's competition here
Rubrik, Inc. (NYSE: RBRK)
CLBT vs RBRK Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, RBRK has a market cap of 17.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while RBRK trades at $86.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas RBRK's P/E ratio is 320.98. In terms of profitability, CLBT's ROE is +0.12%, compared to RBRK's ROE of +0.50%. Regarding short-term risk, CLBT is less volatile compared to RBRK. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check RBRK's competition here
Nutanix, Inc. (NASDAQ: NTNX)
CLBT vs NTNX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NTNX has a market cap of 17.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NTNX trades at $65.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NTNX's P/E ratio is 36.42. In terms of profitability, CLBT's ROE is +0.12%, compared to NTNX's ROE of -3.96%. Regarding short-term risk, CLBT is more volatile compared to NTNX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check NTNX's competition here
Akamai Technologies, Inc. (NASDAQ: AKAM)
CLBT vs AKAM Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, AKAM has a market cap of 15.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while AKAM trades at $106.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas AKAM's P/E ratio is 15.17. In terms of profitability, CLBT's ROE is +0.12%, compared to AKAM's ROE of +0.08%. Regarding short-term risk, CLBT is less volatile compared to AKAM. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check AKAM's competition here
DigitalOcean Holdings, Inc. (NYSE: DOCN)
CLBT vs DOCN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, DOCN has a market cap of 14.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while DOCN trades at $122.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas DOCN's P/E ratio is 73.98. In terms of profitability, CLBT's ROE is +0.12%, compared to DOCN's ROE of +0.55%. Regarding short-term risk, CLBT is less volatile compared to DOCN. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check DOCN's competition here
NortonLifeLock Inc. (NASDAQ: NLOK)
CLBT vs NLOK Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NLOK trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NLOK's P/E ratio is 15.15. In terms of profitability, CLBT's ROE is +0.12%, compared to NLOK's ROE of +0.42%. Regarding short-term risk, CLBT is less volatile compared to NLOK. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NLOK's competition here
Check Point Software Technologies Ltd. (NASDAQ: CHKP)
CLBT vs CHKP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CHKP has a market cap of 13.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CHKP trades at $131.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CHKP's P/E ratio is 10.78. In terms of profitability, CLBT's ROE is +0.12%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, CLBT is more volatile compared to CHKP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CHKP's competition here
GoDaddy Inc. (NYSE: GDDY)
CLBT vs GDDY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GDDY has a market cap of 13B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GDDY trades at $98.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GDDY's P/E ratio is 14.55. In terms of profitability, CLBT's ROE is +0.12%, compared to GDDY's ROE of +6.61%. Regarding short-term risk, CLBT is more volatile compared to GDDY. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GDDY's competition here
PayPay Corporation (NASDAQ: PAYP)
CLBT vs PAYP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PAYP has a market cap of 12.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PAYP trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PAYP's P/E ratio is 41.85. In terms of profitability, CLBT's ROE is +0.12%, compared to PAYP's ROE of +0.36%. Regarding short-term risk, CLBT is more volatile compared to PAYP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PAYP's competition here
Confluent, Inc. (NASDAQ: CFLT)
CLBT vs CFLT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CFLT trades at $30.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CFLT's P/E ratio is -36.03. In terms of profitability, CLBT's ROE is +0.12%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, CLBT is more volatile compared to CFLT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CFLT's competition here
SailPoint, Inc. (NASDAQ: SAIL)
CLBT vs SAIL Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SAIL has a market cap of 9.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SAIL trades at $17.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SAIL's P/E ratio is 61.57. In terms of profitability, CLBT's ROE is +0.12%, compared to SAIL's ROE of -0.03%. Regarding short-term risk, CLBT is less volatile compared to SAIL. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check SAIL's competition here
Altair Engineering Inc. (NASDAQ: ALTR)
CLBT vs ALTR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ALTR trades at $111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ALTR's P/E ratio is 699.06. In terms of profitability, CLBT's ROE is +0.12%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, CLBT is more volatile compared to ALTR. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ALTR's competition here
Anaplan, Inc. (NYSE: PLAN)
CLBT vs PLAN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PLAN trades at $63.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PLAN's P/E ratio is -44.82. In terms of profitability, CLBT's ROE is +0.12%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, CLBT is more volatile compared to PLAN. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PLAN's competition here
Dropbox, Inc. (NASDAQ: DBX)
CLBT vs DBX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, DBX has a market cap of 9.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while DBX trades at $35.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas DBX's P/E ratio is 12.30. In terms of profitability, CLBT's ROE is +0.12%, compared to DBX's ROE of -0.24%. Regarding short-term risk, CLBT is more volatile compared to DBX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check DBX's competition here
Informatica Inc. (NYSE: INFA)
CLBT vs INFA Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while INFA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas INFA's P/E ratio is 826.33. In terms of profitability, CLBT's ROE is +0.12%, compared to INFA's ROE of +0.00%. Regarding short-term risk, CLBT is more volatile compared to INFA. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check INFA's competition here
UiPath Inc. (NYSE: PATH)
CLBT vs PATH Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PATH has a market cap of 7.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PATH trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PATH's P/E ratio is 18.09. In terms of profitability, CLBT's ROE is +0.12%, compared to PATH's ROE of +0.18%. Regarding short-term risk, CLBT is less volatile compared to PATH. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check PATH's competition here
HashiCorp, Inc. (NASDAQ: HCP)
CLBT vs HCP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, HCP has a market cap of 7.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while HCP trades at $34.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas HCP's P/E ratio is -57.97. In terms of profitability, CLBT's ROE is +0.12%, compared to HCP's ROE of -0.16%. Regarding short-term risk, CLBT is more volatile compared to HCP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check HCP's competition here
Ziff Davis, Inc. (NASDAQ: JCOM)
CLBT vs JCOM Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while JCOM trades at $142.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas JCOM's P/E ratio is N/A. In terms of profitability, CLBT's ROE is +0.12%, compared to JCOM's ROE of +0.37%. Regarding short-term risk, CLBT is more volatile compared to JCOM. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check JCOM's competition here
SentinelOne, Inc. (NYSE: S)
CLBT vs S Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, S has a market cap of 6.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while S trades at $19.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas S's P/E ratio is 89.77. In terms of profitability, CLBT's ROE is +0.12%, compared to S's ROE of -0.23%. Regarding short-term risk, CLBT is more volatile compared to S. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check S's competition here
Amdocs Limited (NASDAQ: DOX)
CLBT vs DOX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, DOX has a market cap of 6.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while DOX trades at $61.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas DOX's P/E ratio is 8.46. In terms of profitability, CLBT's ROE is +0.12%, compared to DOX's ROE of +0.13%. Regarding short-term risk, CLBT is more volatile compared to DOX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check DOX's competition here
WEX Inc. (NYSE: WEX)
CLBT vs WEX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, WEX has a market cap of 6.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while WEX trades at $191.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas WEX's P/E ratio is 11.40. In terms of profitability, CLBT's ROE is +0.12%, compared to WEX's ROE of +0.28%. Regarding short-term risk, CLBT is more volatile compared to WEX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check WEX's competition here
Squarespace, Inc. (NYSE: SQSP)
CLBT vs SQSP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SQSP trades at $46.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, CLBT's ROE is +0.12%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, CLBT is more volatile compared to SQSP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SQSP's competition here
New Relic, Inc. (NYSE: NEWR)
CLBT vs NEWR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NEWR trades at $86.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NEWR's P/E ratio is -41.62. In terms of profitability, CLBT's ROE is +0.12%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, CLBT is more volatile compared to NEWR. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check NEWR's competition here
Mobility Global Inc (NYSE: MBGL)
CLBT vs MBGL Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, MBGL has a market cap of 5.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while MBGL trades at $20.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas MBGL's P/E ratio is 48.05. In terms of profitability, CLBT's ROE is +0.12%, compared to MBGL's ROE of +0.01%. Regarding short-term risk, CLBT is more volatile compared to MBGL. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check MBGL's competition here
Netskope, Inc. Class A Common Stock (NASDAQ: NTSK)
CLBT vs NTSK Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NTSK has a market cap of 5.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NTSK trades at $14.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NTSK's P/E ratio is -15.98. In terms of profitability, CLBT's ROE is +0.12%, compared to NTSK's ROE of -4.35%. Regarding short-term risk, CLBT is less volatile compared to NTSK. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NTSK's competition here
Core Scientific, Inc. (NASDAQ: CORZ)
CLBT vs CORZ Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CORZ has a market cap of 5.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CORZ trades at $17.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CORZ's P/E ratio is -9.70. In terms of profitability, CLBT's ROE is +0.12%, compared to CORZ's ROE of +0.99%. Regarding short-term risk, CLBT is less volatile compared to CORZ. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check CORZ's competition here
Core Scientific, Inc. Tranche 2 Warrants (NASDAQ: CORZZ)
CLBT vs CORZZ Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CORZZ has a market cap of 5.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CORZZ trades at $17.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CORZZ's P/E ratio is -3.98. In terms of profitability, CLBT's ROE is +0.12%, compared to CORZZ's ROE of +0.99%. Regarding short-term risk, CLBT is more volatile compared to CORZZ. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CORZZ's competition here
CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCCS)
CLBT vs CCCS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CCCS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CCCS's P/E ratio is -875.00. In terms of profitability, CLBT's ROE is +0.12%, compared to CCCS's ROE of +0.03%. Regarding short-term risk, CLBT is less volatile compared to CCCS. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check CCCS's competition here
ACI Worldwide, Inc. (NASDAQ: ACIW)
CLBT vs ACIW Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ACIW has a market cap of 5.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ACIW trades at $52.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ACIW's P/E ratio is 23.68. In terms of profitability, CLBT's ROE is +0.12%, compared to ACIW's ROE of +0.15%. Regarding short-term risk, CLBT is more volatile compared to ACIW. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ACIW's competition here
Qualys, Inc. (NASDAQ: QLYS)
CLBT vs QLYS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, QLYS has a market cap of 5.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while QLYS trades at $150.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas QLYS's P/E ratio is 19.62. In terms of profitability, CLBT's ROE is +0.12%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, CLBT is less volatile compared to QLYS. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check QLYS's competition here
Varonis Systems, Inc. (NASDAQ: VRNS)
CLBT vs VRNS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, VRNS has a market cap of 5.2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while VRNS trades at $45.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas VRNS's P/E ratio is 196.17. In terms of profitability, CLBT's ROE is +0.12%, compared to VRNS's ROE of -0.27%. Regarding short-term risk, CLBT is more volatile compared to VRNS. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check VRNS's competition here
Core Scientific, Inc. (NASDAQ: CORZW)
CLBT vs CORZW Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CORZW has a market cap of 5.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CORZW trades at $11.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CORZW's P/E ratio is -2.54. In terms of profitability, CLBT's ROE is +0.12%, compared to CORZW's ROE of +0.99%. Regarding short-term risk, CLBT is less volatile compared to CORZW. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check CORZW's competition here
Nuvei Corporation (NASDAQ: NVEI)
CLBT vs NVEI Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NVEI trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NVEI's P/E ratio is 212.44. In terms of profitability, CLBT's ROE is +0.12%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, CLBT is more volatile compared to NVEI. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check NVEI's competition here
Box, Inc. (NYSE: BOX)
CLBT vs BOX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, BOX has a market cap of 4.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while BOX trades at $33.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas BOX's P/E ratio is 22.48. In terms of profitability, CLBT's ROE is +0.12%, compared to BOX's ROE of +2.17%. Regarding short-term risk, CLBT is more volatile compared to BOX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check BOX's competition here
Remitly Global, Inc. (NASDAQ: RELY)
CLBT vs RELY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, RELY has a market cap of 4.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while RELY trades at $21.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas RELY's P/E ratio is 15.82. In terms of profitability, CLBT's ROE is +0.12%, compared to RELY's ROE of +0.33%. Regarding short-term risk, CLBT is more volatile compared to RELY. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check RELY's competition here
Paymentus Holdings, Inc. (NYSE: PAY)
CLBT vs PAY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PAY has a market cap of 4.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PAY trades at $36.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PAY's P/E ratio is 43.80. In terms of profitability, CLBT's ROE is +0.12%, compared to PAY's ROE of +0.15%. Regarding short-term risk, CLBT is more volatile compared to PAY. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PAY's competition here
BlackBerry Limited (NYSE: BB)
CLBT vs BB Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, BB has a market cap of 4.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while BB trades at $7.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas BB's P/E ratio is 40.32. In terms of profitability, CLBT's ROE is +0.12%, compared to BB's ROE of +0.08%. Regarding short-term risk, CLBT is more volatile compared to BB. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check BB's competition here
Dlocal Limited (NASDAQ: DLO)
CLBT vs DLO Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, DLO has a market cap of 4.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while DLO trades at $14.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas DLO's P/E ratio is 20.08. In terms of profitability, CLBT's ROE is +0.12%, compared to DLO's ROE of +0.38%. Regarding short-term risk, CLBT is more volatile compared to DLO. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check DLO's competition here
Shift4 Payments, Inc. (NYSE: FOUR)
CLBT vs FOUR Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, FOUR has a market cap of 4.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while FOUR trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas FOUR's P/E ratio is 8.40. In terms of profitability, CLBT's ROE is +0.12%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, CLBT is less volatile compared to FOUR. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check FOUR's competition here
EngageSmart, Inc. (NYSE: ESMT)
CLBT vs ESMT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ESMT trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ESMT's P/E ratio is 153.67. In terms of profitability, CLBT's ROE is +0.12%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, CLBT is more volatile compared to ESMT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ESMT's competition here
Tenable Holdings, Inc. (NASDAQ: TENB)
CLBT vs TENB Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, TENB has a market cap of 3.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while TENB trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas TENB's P/E ratio is 17.61. In terms of profitability, CLBT's ROE is +0.12%, compared to TENB's ROE of +0.02%. Regarding short-term risk, CLBT is less volatile compared to TENB. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check TENB's competition here
SolarWinds Corporation (NYSE: SWI)
CLBT vs SWI Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SWI trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SWI's P/E ratio is 28.89. In terms of profitability, CLBT's ROE is +0.12%, compared to SWI's ROE of +0.08%. Regarding short-term risk, CLBT is more volatile compared to SWI. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SWI's competition here
EVO Payments, Inc. (NASDAQ: EVOP)
CLBT vs EVOP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while EVOP trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas EVOP's P/E ratio is -309.00. In terms of profitability, CLBT's ROE is +0.12%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, CLBT is more volatile compared to EVOP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check EVOP's competition here
NetScout Systems, Inc. (NASDAQ: NTCT)
CLBT vs NTCT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NTCT has a market cap of 2.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NTCT trades at $38.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NTCT's P/E ratio is 14.30. In terms of profitability, CLBT's ROE is +0.12%, compared to NTCT's ROE of +0.07%. Regarding short-term risk, CLBT is more volatile compared to NTCT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check NTCT's competition here
Euronet Worldwide, Inc. (NASDAQ: EEFT)
CLBT vs EEFT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, EEFT has a market cap of 2.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while EEFT trades at $72.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas EEFT's P/E ratio is 7.11. In terms of profitability, CLBT's ROE is +0.12%, compared to EEFT's ROE of +0.23%. Regarding short-term risk, CLBT is more volatile compared to EEFT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check EEFT's competition here
AvePoint, Inc. (NASDAQ: AVPT)
CLBT vs AVPT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, AVPT has a market cap of 2.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while AVPT trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas AVPT's P/E ratio is 35.17. In terms of profitability, CLBT's ROE is +0.12%, compared to AVPT's ROE of +0.16%. Regarding short-term risk, CLBT is more volatile compared to AVPT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check AVPT's competition here
Teradata Corporation (NYSE: TDC)
CLBT vs TDC Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, TDC has a market cap of 2.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while TDC trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas TDC's P/E ratio is 9.19. In terms of profitability, CLBT's ROE is +0.12%, compared to TDC's ROE of +1.15%. Regarding short-term risk, CLBT is more volatile compared to TDC. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check TDC's competition here
Appian Corporation (NASDAQ: APPN)
CLBT vs APPN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, APPN has a market cap of 2.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while APPN trades at $34.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas APPN's P/E ratio is 39.95. In terms of profitability, CLBT's ROE is +0.12%, compared to APPN's ROE of +0.16%. Regarding short-term risk, CLBT is more volatile compared to APPN. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check APPN's competition here
StoneCo Ltd. (NASDAQ: STNE)
CLBT vs STNE Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, STNE has a market cap of 2.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while STNE trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas STNE's P/E ratio is 5.73. In terms of profitability, CLBT's ROE is +0.12%, compared to STNE's ROE of +0.30%. Regarding short-term risk, CLBT is less volatile compared to STNE. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check STNE's competition here
Payoneer Global Inc. (NASDAQ: PAYO)
CLBT vs PAYO Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PAYO has a market cap of 2.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PAYO trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PAYO's P/E ratio is 44.50. In terms of profitability, CLBT's ROE is +0.12%, compared to PAYO's ROE of +0.07%. Regarding short-term risk, CLBT is more volatile compared to PAYO. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PAYO's competition here
CSG Systems International, Inc. (NASDAQ: CSGS)
CLBT vs CSGS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while CSGS trades at $80.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas CSGS's P/E ratio is 36.02. In terms of profitability, CLBT's ROE is +0.12%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, CLBT is more volatile compared to CSGS. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check CSGS's competition here
LiveRamp Holdings, Inc. (NYSE: RAMP)
CLBT vs RAMP Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, RAMP has a market cap of 2.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while RAMP trades at $37.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas RAMP's P/E ratio is 15.18. In terms of profitability, CLBT's ROE is +0.12%, compared to RAMP's ROE of +0.16%. Regarding short-term risk, CLBT is more volatile compared to RAMP. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check RAMP's competition here
AvidXchange Holdings, Inc. (NASDAQ: AVDX)
CLBT vs AVDX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while AVDX trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas AVDX's P/E ratio is -250.00. In terms of profitability, CLBT's ROE is +0.12%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, CLBT is more volatile compared to AVDX. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check AVDX's competition here
Getnet Adquirência e Serviços para Meios de Pagamento S.A. (NASDAQ: GETVV)
CLBT vs GETVV Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GETVV trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GETVV's P/E ratio is N/A. In terms of profitability, CLBT's ROE is +0.12%, compared to GETVV's ROE of N/A. Regarding short-term risk, CLBT is less volatile compared to GETVV. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check GETVV's competition here
NextNav Inc. (NASDAQ: NN)
CLBT vs NN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NN has a market cap of 2.1B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NN trades at $15.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NN's P/E ratio is -17.86. In terms of profitability, CLBT's ROE is +0.12%, compared to NN's ROE of -3.29%. Regarding short-term risk, CLBT is less volatile compared to NN. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NN's competition here
ForgeRock, Inc. (NYSE: FORG)
CLBT vs FORG Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while FORG trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas FORG's P/E ratio is -22.53. In terms of profitability, CLBT's ROE is +0.12%, compared to FORG's ROE of -0.20%. Regarding short-term risk, CLBT is less volatile compared to FORG. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check FORG's competition here
GigaCloud Technology Inc. (NASDAQ: GCT)
CLBT vs GCT Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GCT has a market cap of 1.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GCT trades at $51.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GCT's P/E ratio is 12.26. In terms of profitability, CLBT's ROE is +0.12%, compared to GCT's ROE of +0.31%. Regarding short-term risk, CLBT is more volatile compared to GCT. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GCT's competition here
GreenSky, Inc. (NASDAQ: GSKY)
CLBT vs GSKY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GSKY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GSKY's P/E ratio is 18.61. In terms of profitability, CLBT's ROE is +0.12%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, CLBT is more volatile compared to GSKY. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GSKY's competition here
Bandwidth Inc. (NASDAQ: BAND)
CLBT vs BAND Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, BAND has a market cap of 1.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while BAND trades at $56.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas BAND's P/E ratio is 38.69. In terms of profitability, CLBT's ROE is +0.12%, compared to BAND's ROE of +0.00%. Regarding short-term risk, CLBT is less volatile compared to BAND. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check BAND's competition here
A10 Networks, Inc. (NYSE: ATEN)
CLBT vs ATEN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ATEN has a market cap of 1.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ATEN trades at $24.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ATEN's P/E ratio is 25.23. In terms of profitability, CLBT's ROE is +0.12%, compared to ATEN's ROE of +0.20%. Regarding short-term risk, CLBT is more volatile compared to ATEN. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ATEN's competition here
Getnet Adquirência e Serviços para Meios de Pagamento S.A. (NASDAQ: GET)
CLBT vs GET Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GET trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GET's P/E ratio is 31.33. In terms of profitability, CLBT's ROE is +0.12%, compared to GET's ROE of N/A. Regarding short-term risk, CLBT is more volatile compared to GET. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GET's competition here
Nayax Ltd. (NASDAQ: NYAX)
CLBT vs NYAX Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, NYAX has a market cap of 1.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while NYAX trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas NYAX's P/E ratio is 73.75. In terms of profitability, CLBT's ROE is +0.12%, compared to NYAX's ROE of +0.04%. Regarding short-term risk, CLBT is less volatile compared to NYAX. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check NYAX's competition here
Pagaya Technologies Ltd. (NASDAQ: PGY)
CLBT vs PGY Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PGY has a market cap of 1.7B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PGY trades at $19.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PGY's P/E ratio is 13.23. In terms of profitability, CLBT's ROE is +0.12%, compared to PGY's ROE of +0.24%. Regarding short-term risk, CLBT is less volatile compared to PGY. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check PGY's competition here
Sterling Check Corp. (NASDAQ: STER)
CLBT vs STER Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while STER trades at $16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas STER's P/E ratio is -98.47. In terms of profitability, CLBT's ROE is +0.12%, compared to STER's ROE of -0.00%. Regarding short-term risk, CLBT is more volatile compared to STER. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check STER's competition here
Progress Software Corporation (NASDAQ: PRGS)
CLBT vs PRGS Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, PRGS has a market cap of 1.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while PRGS trades at $39.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas PRGS's P/E ratio is 6.41. In terms of profitability, CLBT's ROE is +0.12%, compared to PRGS's ROE of +0.18%. Regarding short-term risk, CLBT is more volatile compared to PRGS. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check PRGS's competition here
Marqeta, Inc. (NASDAQ: MQ)
CLBT vs MQ Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, MQ has a market cap of 1.6B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while MQ trades at $16.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas MQ's P/E ratio is 168.00. In terms of profitability, CLBT's ROE is +0.12%, compared to MQ's ROE of +0.02%. Regarding short-term risk, CLBT is more volatile compared to MQ. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check MQ's competition here
Zuora, Inc. (NYSE: ZUO)
CLBT vs ZUO Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while ZUO trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas ZUO's P/E ratio is -19.65. In terms of profitability, CLBT's ROE is +0.12%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, CLBT is more volatile compared to ZUO. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check ZUO's competition here
Sumo Logic, Inc. (NASDAQ: SUMO)
CLBT vs SUMO Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while SUMO trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas SUMO's P/E ratio is -11.36. In terms of profitability, CLBT's ROE is +0.12%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, CLBT is more volatile compared to SUMO. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check SUMO's competition here
Global Blue Group Holding AG (NYSE: GB)
CLBT vs GB Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while GB trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas GB's P/E ratio is 18.27. In terms of profitability, CLBT's ROE is +0.12%, compared to GB's ROE of +0.88%. Regarding short-term risk, CLBT is more volatile compared to GB. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check GB's competition here
Couchbase, Inc. (NASDAQ: BASE)
CLBT vs BASE Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, BASE has a market cap of 1.4B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while BASE trades at $24.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas BASE's P/E ratio is -17.38. In terms of profitability, CLBT's ROE is +0.12%, compared to BASE's ROE of -0.33%. Regarding short-term risk, CLBT is more volatile compared to BASE. This indicates higher risk in terms of short-term price fluctuations for CLBT.Check BASE's competition here
Boost Run Inc. Class A Common Stock (NASDAQ: BRUN)
CLBT vs BRUN Comparison September 2026
Cellebrite DI Ltd. (NASDAQ: CLBT) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLBT stands at 2.8B. In comparison, BRUN has a market cap of 1.3B. Regarding current trading prices, CLBT is priced at $11.23 on the NASDAQ, while BRUN trades at $16.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLBT currently has a P/E ratio of 48.32, whereas BRUN's P/E ratio is -34.65. In terms of profitability, CLBT's ROE is +0.12%, compared to BRUN's ROE of -2.62%. Regarding short-term risk, CLBT is less volatile compared to BRUN. This indicates lower risk in terms of short-term price fluctuations for CLBT.Check BRUN's competition here